Esperite N.V.: Samples and Database are safe. The recent articles published about CryoSave on loss of samples are poorly informed and defamatory.
10 févr. 2020 01h17 HE
|
Esperite N.V.
Samples and Database are safe Amsterdam, The Netherlands – 10 February 2020 Esperite N.V. (Euronext: ESP, “Esperite”) has noticed several articles in the news, online channels and information blogs...
Esperite (ESP) disputes the Court verdict and appeals the bankruptcy order.
13 oct. 2019 23h59 HE
|
Esperite N.V.
Amsterdam, The Netherlands – 14 October 2019 The Court in Gelderland, Netherlands, on October 8th, 2019, has declared Esperite in bankruptcy. The board of directors of Esperite N.V. disputes the...
Esperite N.V.: announces termination of audit engagement in relation to 2018 annual report
04 juil. 2019 02h58 HE
|
Esperite N.V.
ESPERITE (ESP) announces termination of audit engagement in relation to 2018 annual report Amsterdam, The Netherlands – 3 July 2019Esperite N.V. (Euronext: ESP, “Esperite”) announces that its...
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE.
02 juil. 2019 02h47 HE
|
Esperite N.V.
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE. ...